Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 25, 2019 Filed Oct 30, 2019 00:41 UTC |
Lesaicherre Pierre-YvesDirector · President and CEO
|
Exercise / conversionPerformance Stock Units · Derivative | 37,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-054369 · doc4.xml · derivative · entry 3 Lesaicherre Pierre-Yves · CIK 0001723434 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,063 shares Expires 2022-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit represented a contingent right to receive one share of NANO common stock. The grant was made at 150% of target. The performance stock units vested at target, resulting in the issuance of 2/3 of the shares subject to the performance stock unit, and the remainder of the performance stock unit being cancelled. F1 · derivative.exercise_date: Each performance stock unit represented a contingent right to receive one share of NANO common stock. The grant was made at 150% of target. The performance stock units vested at target, resulting in the issuance of 2/3 of the shares subject to the performance stock unit, and the remainder of the performance stock unit being cancelled. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:41 UTC |
Lesaicherre Pierre-YvesDirector · President and CEO
|
Tax withholdingCommon Stock | 92,134 | $35.33 | $3,255,094.22 |
DisclosureSEC source: 0001209191-19-054369 · doc4.xml · nonDerivative · entry 2 Lesaicherre Pierre-Yves · CIK 0001723434 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,606 Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:41 UTC |
Lesaicherre Pierre-YvesDirector · President and CEO
|
Exercise / conversionCommon Stock | 83,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-054369 · doc4.xml · nonDerivative · entry 1 Lesaicherre Pierre-Yves · CIK 0001723434 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 01:42 UTC |
KOCH ROBERT ALANVP & General Counsel
|
GrantCommon Stock | 10,709 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026264 · doc4.xml · nonDerivative · entry 2 KOCH ROBERT ALAN · CIK 0001244761 · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,656 F2 · shares: These restricted stock units ("RSUs") were originally granted under the Rudolph Technologies, Inc. 2018 Stock Plan (the "Plan") and vest periodically so long as the reporting person remains employed by Onto Innovation or one of its affiliates on each applicable vesting date. At the Effective Time, Onto Innovation assumed the Plan and related award agreements and the existing RSUs became restricted stock units of Onto Innovation, subject to the Exchange Ratio. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 01:42 UTC |
KOCH ROBERT ALANVP & General Counsel
|
GrantCommon Stock | 37,947 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026264 · doc4.xml · nonDerivative · entry 1 KOCH ROBERT ALAN · CIK 0001244761 · VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,947 F1 · shares: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 01:40 UTC |
Cassese Vita ADirector
|
GrantCommon Stock | 3,297 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026260 · doc4.xml · nonDerivative · entry 2 Cassese Vita A · CIK 0001749068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,433 F2 · shares: These restricted stock units ("RSUs") were originally granted under the Rudolph Technologies, Inc. 2018 Stock Plan (the "Plan") and vest periodically so long as the reporting person remains employed by Onto Innovation or one of its affiliates on each applicable vesting date. At the Effective Time, Onto Innovation assumed the Plan and related award agreements and the existing RSUs became restricted stock units of Onto Innovation, subject to the Exchange Ratio. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 01:40 UTC |
Cassese Vita ADirector
|
GrantCommon Stock | 3,136 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026260 · doc4.xml · nonDerivative · entry 1 Cassese Vita A · CIK 0001749068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,136 F1 · shares: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 01:36 UTC |
MILLER DAVID BRIANDirector
|
GrantCommon Stock | 3,297 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026256 · doc4.xml · nonDerivative · entry 2 MILLER DAVID BRIAN · CIK 0001233488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,209 F2 · shares: These restricted stock units ("RSUs") were originally granted under the Rudolph Technologies, Inc. 2018 Stock Plan (the "Plan") and vest periodically so long as the reporting person remains employed by Onto Innovation or one of its affiliates on each applicable vesting date. At the Effective Time, Onto Innovation assumed the Plan and related award agreements and the existing RSUs became restricted stock units of Onto Innovation, subject to the Exchange Ratio. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 01:36 UTC |
MILLER DAVID BRIANDirector
|
GrantCommon Stock | 13,912 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026256 · doc4.xml · nonDerivative · entry 1 MILLER DAVID BRIAN · CIK 0001233488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,912 F1 · shares: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 01:36 UTC |
da Silveira Elvino MVP & GM of LSG
|
GrantCommon Stock | 8,649 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026255 · doc4.xml · nonDerivative · entry 2 da Silveira Elvino M · CIK 0001564707 · VP & GM of LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,867 F2 · shares: These restricted stock units ("RSUs") were originally granted under the Rudolph Technologies, Inc. 2018 Stock Plan (the "Plan") and vest periodically so long as the reporting person remains employed by Onto Innovation or one of its affiliates on each applicable vesting date. At the Effective Time, Onto Innovation assumed the Plan and related award agreements and the existing RSUs became restricted stock units of Onto Innovation, subject to the Exchange Ratio. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 01:36 UTC |
da Silveira Elvino MVP & GM of LSG
|
GrantCommon Stock | 23,218 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026255 · doc4.xml · nonDerivative · entry 1 da Silveira Elvino M · CIK 0001564707 · VP & GM of LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,218 F1 · shares: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 01:35 UTC |
Aukerman Jeffrey A.Director
|
GrantCommon Stock | 3,297 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026254 · doc4.xml · nonDerivative · entry 2 Aukerman Jeffrey A. · CIK 0001628505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,760 F2 · shares: These restricted stock units ("RSUs") were originally granted under the Rudolph Technologies, Inc. 2018 Stock Plan (the "Plan") and vest periodically so long as the reporting person remains employed by Onto Innovation or one of its affiliates on each applicable vesting date. At the Effective Time, Onto Innovation assumed the Plan and related award agreements and the existing RSUs became restricted stock units of Onto Innovation, subject to the Exchange Ratio. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 01:35 UTC |
Aukerman Jeffrey A.Director
|
GrantCommon Stock | 20,463 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026254 · doc4.xml · nonDerivative · entry 1 Aukerman Jeffrey A. · CIK 0001628505 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Investment LLC Disclosed balance after: 20,463 F1 · shares: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:45 UTC |
Kocher RollinSVP, Sales and Marketing
|
Exercise / conversionPerformance Stock Units · Derivative | 1,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-054376 · doc4.xml · derivative · entry 4 Kocher Rollin · CIK 0001684779 · SVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,950 shares Expires 2020-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance stock unit represented a contingent right to receive one share of NANO common stock. The grant was made at 150% of target. The performance stock units were converted at target, resulting in the conversion of 2/3 of the shares subject to the performance stock unit into restricted stock units, and the remainder of the performance stock unit being cancelled. F2 · derivative.exercise_date: Each performance stock unit represented a contingent right to receive one share of NANO common stock. The grant was made at 150% of target. The performance stock units were converted at target, resulting in the conversion of 2/3 of the shares subject to the performance stock unit into restricted stock units, and the remainder of the performance stock unit being cancelled. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:45 UTC |
Kocher RollinSVP, Sales and Marketing
|
Exercise / conversionPerformance Stock Units · Derivative | 4,847 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-054376 · doc4.xml · derivative · entry 3 Kocher Rollin · CIK 0001684779 · SVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,847 shares Expires 2021-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance stock unit represented a contingent right to receive one share of NANO common stock. The grant was made at 150% of target. The performance stock units were converted at target, resulting in the conversion of 2/3 of the shares subject to the performance stock unit into restricted stock units, and the remainder of the performance stock unit being cancelled. F2 · derivative.exercise_date: Each performance stock unit represented a contingent right to receive one share of NANO common stock. The grant was made at 150% of target. The performance stock units were converted at target, resulting in the conversion of 2/3 of the shares subject to the performance stock unit into restricted stock units, and the remainder of the performance stock unit being cancelled. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:45 UTC |
Kocher RollinSVP, Sales and Marketing
|
Exercise / conversionPerformance Stock Units · Derivative | 6,366 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-054376 · doc4.xml · derivative · entry 2 Kocher Rollin · CIK 0001684779 · SVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,366 shares Expires 2022-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance stock unit represented a contingent right to receive one share of NANO common stock. The grant was made at 150% of target. The performance stock units were converted at target, resulting in the conversion of 2/3 of the shares subject to the performance stock unit into restricted stock units, and the remainder of the performance stock unit being cancelled. F2 · derivative.exercise_date: Each performance stock unit represented a contingent right to receive one share of NANO common stock. The grant was made at 150% of target. The performance stock units were converted at target, resulting in the conversion of 2/3 of the shares subject to the performance stock unit into restricted stock units, and the remainder of the performance stock unit being cancelled. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:45 UTC |
Kocher RollinSVP, Sales and Marketing
|
Exercise / conversionCommon Stock | 8,776 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-054376 · doc4.xml · nonDerivative · entry 1 Kocher Rollin · CIK 0001684779 · SVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of NANO common stock. The restricted stock units vest on an annual basis, in equal 1/3 increments, over a three-year period from the award date. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:43 UTC |
Barnhart JamesSVP, Business Operations
|
Tax withholdingCommon Stock | 12,380 | $35.33 | $437,385.40 |
DisclosureSEC source: 0001209191-19-054372 · doc4.xml · nonDerivative · entry 1 Barnhart James · CIK 0001734406 · SVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,046 Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:44 UTC |
Taylor Janet ThereseGeneral Counsel
|
Tax withholdingCommon Stock | 8,413 | $35.33 | $297,231.29 |
DisclosureSEC source: 0001209191-19-054374 · doc4.xml · nonDerivative · entry 1 Taylor Janet Therese · CIK 0001647625 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,110 Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 20:30 UTC |
Chan Chun HoyVice President, Sales
|
GrantCommon Stock | 9,267 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026352 · doc4.xml · nonDerivative · entry 2 Chan Chun Hoy · CIK 0001631609 · Vice President, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,339 F2 · shares: These restricted stock units ("RSUs") were originally granted under the Rudolph Technologies, Inc. 2018 Stock Plan (the "Plan") and vest periodically so long as the reporting person remains employed by Onto Innovation or one of its affiliates on each applicable vesting date. At the Effective Time, Onto Innovation assumed the Plan and related award agreements and the existing RSUs became restricted stock units of Onto Innovation, subject to the Exchange Ratio. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 20:30 UTC |
Chan Chun HoyVice President, Sales
|
GrantCommon Stock | 15,072 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026352 · doc4.xml · nonDerivative · entry 1 Chan Chun Hoy · CIK 0001631609 · Vice President, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,072 F1 · shares: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 10:08 UTC |
Plisinski Michael PDirector · Chief Executive Officer
|
GrantCommon Stock | 62,313 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026285 · doc4.xml · nonDerivative · entry 2 Plisinski Michael P · CIK 0001325550 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,734 F2 · shares: These restricted stock units ("RSUs") were originally granted under the Rudolph Technologies, Inc. 2018 Stock Plan (the "Plan") and vest periodically so long as the reporting person remains employed by Onto Innovation or one of its affiliates on each applicable vesting date. At the Effective Time, Onto Innovation assumed the Plan and related award agreements and the existing RSUs became restricted stock units of Onto Innovation, subject to the Exchange Ratio. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 10:08 UTC |
Plisinski Michael PDirector · Chief Executive Officer
|
GrantCommon Stock | 236,421 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026285 · doc4.xml · nonDerivative · entry 1 Plisinski Michael P · CIK 0001325550 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,421 F1 · shares: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 10:06 UTC |
Jin JuSEE REMARKS
|
GrantCommon Stock | 2,976 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-19-026284 · doc4.xml · nonDerivative · entry 1 Jin Ju · CIK 0001783605 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,976 F2 · shares: These restricted stock units ("RSUs") were originally granted under the Rudolph Technologies, Inc. 2018 Stock Plan (the "Plan") and vest periodically so long as the reporting person remains employed by Onto Innovation or one of its affiliates on each applicable vesting date. At the Effective Time, Onto Innovation assumed the Plan and related award agreements and the existing RSUs became restricted stock units of Onto Innovation, subject to the Exchange Ratio. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| October 25, 2019 Filed Nov 12, 2019 21:31 UTC Amendment |
Lesaicherre Pierre-YvesFormer President and CEO
|
Exercise / conversionPerformance Stock Units · Derivative | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-056016 · doc4a.xml · derivative · entry 3 Lesaicherre Pierre-Yves · CIK 0001723434 · Former President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Comon Stock · 62,500 shares Expires 2020-11-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This performance stock unit represented a contingent right to receive shares of NANO common stock. The performance stock unit vested with respect to 59,480 shares, resulting in 59,480 shares released at target, and the remainder was cancelled. F2 · derivative.exercise_date: This performance stock unit represented a contingent right to receive shares of NANO common stock. The performance stock unit vested with respect to 59,480 shares, resulting in 59,480 shares released at target, and the remainder was cancelled. Read SEC document |
| October 25, 2019 Filed Nov 12, 2019 21:31 UTC Amendment |
Lesaicherre Pierre-YvesFormer President and CEO
|
Tax withholdingCommon Stock | 102,989 | $35.33 | $3,638,601.37 |
DisclosureSEC source: 0001209191-19-056016 · doc4a.xml · nonDerivative · entry 2 Lesaicherre Pierre-Yves · CIK 0001723434 · Former President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,564 F1 · shares: This amendment to Form 4 is being filed to correct the number of shares issued upon the vesting of a performance stock unit and the number of shares withheld to cover taxes, which also resulted in a greater number of shares held after such transactions. F1 · balance_after: This amendment to Form 4 is being filed to correct the number of shares issued upon the vesting of a performance stock unit and the number of shares withheld to cover taxes, which also resulted in a greater number of shares held after such transactions. Read SEC document |
| October 25, 2019 Filed Nov 12, 2019 21:31 UTC Amendment |
Lesaicherre Pierre-YvesFormer President and CEO
|
Exercise / conversionCommon Stock | 101,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-056016 · doc4a.xml · nonDerivative · entry 1 Lesaicherre Pierre-Yves · CIK 0001723434 · Former President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This amendment to Form 4 is being filed to correct the number of shares issued upon the vesting of a performance stock unit and the number of shares withheld to cover taxes, which also resulted in a greater number of shares held after such transactions. F1 · balance_after: This amendment to Form 4 is being filed to correct the number of shares issued upon the vesting of a performance stock unit and the number of shares withheld to cover taxes, which also resulted in a greater number of shares held after such transactions. Read SEC document |
| October 25, 2019 Filed Jan 15, 2020 20:11 UTC Amendment |
Aukerman Jeffrey A.Director
|
GrantCommon Stock | 3,297 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001407682-20-000009 · primary_doc.xml · nonDerivative · entry 2 Aukerman Jeffrey A. · CIK 0001628505 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,297 F2 · shares: These restricted stock units ("RSUs") were originally granted under the Rudolph Technologies, Inc. 2018 Stock Plan (the "Plan") and vest periodically so long as the reporting person remains employed by Onto Innovation or one of its affiliates on each applicable vesting date. At the Effective Time, Onto Innovation assumed the Plan and related award agreements and the existing RSUs became restricted stock units of Onto Innovation, subject to the Exchange Ratio. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. F3 · balance_after: The Form 4 filed on October 29, 2019, inadvertently gave the wrong number for the amount of securities beneficially owned directly following the reported transaction. This amendment fixes such error. Read SEC document |
| October 25, 2019 Filed Jan 15, 2020 20:11 UTC Amendment |
Aukerman Jeffrey A.Director
|
GrantCommon Stock | 20,463 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001407682-20-000009 · primary_doc.xml · nonDerivative · entry 1 Aukerman Jeffrey A. · CIK 0001628505 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Investment LLC Disclosed balance after: 20,463 F1 · shares: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. F1 · price: On October 25, 2019, pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), Rudolph Technologies, Inc. ("Rudolph") and Nanometrics Incorporated ("Nanometrics") effected an all-stock merger of equals to combine their respective businesses in which a wholly-owned subsidiary of Nanometrics merged with and into Rudolph, with Rudolph surviving as a wholly-owned subsidiary of Nanometrics (the "Merger"). Pursuant to the Merger Agreement, upon completion of the Merger, Nanometrics changed its name to "Onto Innovation Inc." ("Onto Innovation") and each issued and outstanding share of Rudolph common stock was converted into the right to receive 0.8042 shares of Nanometrics common stock (the "Exchange Ratio"), with cash paid in lieu of fractional shares. Read SEC document |
| July 23, 2019 Filed Jul 23, 2019 23:23 UTC |
Rhine Bruce CDirector
|
GiftCommon Stock | 1,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-042988 · doc4.xml · nonDerivative · entry 1 Rhine Bruce C · CIK 0001369134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 692,117 Read SEC document |
| July 16, 2019 Filed Jul 16, 2019 23:43 UTC |
Stultz Timothy JDirector
|
GiftCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-042282 · doc4.xml · nonDerivative · entry 1 Stultz Timothy J · CIK 0001410399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,099 Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:17 UTC |
Kocher RollinSVP, Sales and Marketing
|
SaleCommon Stock | 693 | $35.27 | $24,442.11 |
DisclosureSEC source: 0001209191-19-040245 · doc4.xml · nonDerivative · entry 1 Kocher Rollin · CIK 0001684779 · SVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,638 F1 · balance_after: Includes 693 shares purchased on June 30, 2019 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| July 01, 2019 Filed Jul 2, 2019 20:13 UTC |
Swyt GregVP, Finance
|
SaleCommon Stock | 32 | $35.27 | $1,128.64 |
DisclosureSEC source: 0001209191-19-040212 · doc4.xml · nonDerivative · entry 1 Swyt Greg · CIK 0001723433 · VP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,627 F1 · balance_after: Includes 32 shares purchased on June 30, 2019 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:24 UTC |
Heidrich KevinSVP, Corporate Development
|
OtherCommon Stock | 639 | $23.38 | $14,942.06 |
DisclosureSEC source: 0001209191-19-040288 · doc4.xml · nonDerivative · entry 1 Heidrich Kevin · CIK 0001635121 · SVP, Corporate Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,239 F1 · kind: Shares were purchased pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:25 UTC |
Barnhart JamesSVP, Business Operations
|
OtherCommon Stock | 493 | $23.38 | $11,528.07 |
DisclosureSEC source: 0001209191-19-040291 · doc4.xml · nonDerivative · entry 1 Barnhart James · CIK 0001734406 · SVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,426 F1 · kind: Shares were purchased pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:18 UTC |
Taylor Janet ThereseGeneral Counsel
|
OtherCommon Stock | 662 | $23.38 | $15,479.88 |
DisclosureSEC source: 0001209191-19-040248 · doc4.xml · nonDerivative · entry 1 Taylor Janet Therese · CIK 0001647625 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,523 F1 · kind: Shares were purchased pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 30, 2019 Filed Jul 2, 2019 20:20 UTC |
Lesaicherre Pierre-YvesDirector · President and CEO
|
OtherCommon Stock | 908 | $23.38 | $21,232.22 |
DisclosureSEC source: 0001209191-19-040267 · doc4.xml · nonDerivative · entry 1 Lesaicherre Pierre-Yves · CIK 0001723434 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,256 F1 · kind: Shares were purchased pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 28, 2019 Filed Jul 1, 2019 23:21 UTC |
Stultz Timothy JDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 17,986 | $0.00 Strike: $15.85 | $0.00 |
DisclosureSEC source: 0001209191-19-039892 · doc4.xml · derivative · entry 6 Stultz Timothy J · CIK 0001410399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,986 shares Expires 2020-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to Rule 10b5-1 Plan adopted November 26, 2018. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| June 28, 2019 Filed Jul 1, 2019 23:21 UTC |
Stultz Timothy JDirector
|
SaleCommon Stock | 17,986 | $35.10 | $631,308.60 |
DisclosureSEC source: 0001209191-19-039892 · doc4.xml · nonDerivative · entry 4 Stultz Timothy J · CIK 0001410399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,249 F1 · kind: Transaction pursuant to Rule 10b5-1 Plan adopted November 26, 2018. F3 · price: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $35.00 to $35.695. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| June 28, 2019 Filed Jul 1, 2019 23:21 UTC |
Stultz Timothy JDirector
|
Exercise / conversionCommon Stock | 17,986 | $15.85 | $285,078.10 |
DisclosureSEC source: 0001209191-19-039892 · doc4.xml · nonDerivative · entry 3 Stultz Timothy J · CIK 0001410399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to Rule 10b5-1 Plan adopted November 26, 2018. Read SEC document |
| June 27, 2019 Filed Jul 1, 2019 23:21 UTC |
Stultz Timothy JDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $15.85 | $0.00 |
DisclosureSEC source: 0001209191-19-039892 · doc4.xml · derivative · entry 5 Stultz Timothy J · CIK 0001410399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,986 Underlying: Common Stock · 30,000 shares Expires 2020-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to Rule 10b5-1 Plan adopted November 26, 2018. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| June 27, 2019 Filed Jul 1, 2019 23:21 UTC |
Stultz Timothy JDirector
|
SaleCommon Stock | 30,000 | $35.00 | $1,050,000.00 |
DisclosureSEC source: 0001209191-19-039892 · doc4.xml · nonDerivative · entry 2 Stultz Timothy J · CIK 0001410399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,249 F1 · kind: Transaction pursuant to Rule 10b5-1 Plan adopted November 26, 2018. F2 · price: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $35.00 to $35.10. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| June 27, 2019 Filed Jul 1, 2019 23:21 UTC |
Stultz Timothy JDirector
|
Exercise / conversionCommon Stock | 30,000 | $15.85 | $475,500.00 |
DisclosureSEC source: 0001209191-19-039892 · doc4.xml · nonDerivative · entry 1 Stultz Timothy J · CIK 0001410399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to Rule 10b5-1 Plan adopted November 26, 2018. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 21:46 UTC |
Stultz Timothy JDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 12,014 | $0.00 Strike: $15.85 | $0.00 |
DisclosureSEC source: 0001209191-19-039167 · doc4.xml · derivative · entry 3 Stultz Timothy J · CIK 0001410399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,986 Underlying: Common Stock · 12,014 shares Expires 2020-03-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to Rule 10b5-1 Plan adopted November 26, 2018. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 21:46 UTC |
Stultz Timothy JDirector
|
SaleCommon Stock | 12,014 | $35.17 | $422,532.38 |
DisclosureSEC source: 0001209191-19-039167 · doc4.xml · nonDerivative · entry 2 Stultz Timothy J · CIK 0001410399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,249 F1 · kind: Transaction pursuant to Rule 10b5-1 Plan adopted November 26, 2018. F2 · price: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $35.00 to $35.59. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| June 24, 2019 Filed Jun 26, 2019 21:46 UTC |
Stultz Timothy JDirector
|
Exercise / conversionCommon Stock | 12,014 | $15.85 | $190,421.90 |
DisclosureSEC source: 0001209191-19-039167 · doc4.xml · nonDerivative · entry 1 Stultz Timothy J · CIK 0001410399 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction pursuant to Rule 10b5-1 Plan adopted November 26, 2018. Read SEC document |
| June 02, 2019 Filed Jun 3, 2019 23:22 UTC |
Swyt GregVP, Finance
|
Tax withholdingCommon Stock | 275 | $28.45 | $7,823.75 |
DisclosureSEC source: 0001209191-19-034075 · doc4.xml · nonDerivative · entry 2 Swyt Greg · CIK 0001723433 · VP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,627 Read SEC document |
| June 01, 2019 Filed Jun 3, 2019 23:22 UTC |
Swyt GregVP, Finance
|
Tax withholdingCommon Stock | 432 | $28.45 | $12,290.40 |
DisclosureSEC source: 0001209191-19-034075 · doc4.xml · nonDerivative · entry 1 Swyt Greg · CIK 0001723433 · VP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,902 Read SEC document |
| June 01, 2019 Filed Jun 3, 2019 23:21 UTC |
Barnhart JamesSVP, Business Operations
|
Tax withholdingCommon Stock | 2,595 | $28.45 | $73,827.75 |
DisclosureSEC source: 0001209191-19-034074 · doc4.xml · nonDerivative · entry 1 Barnhart James · CIK 0001734406 · SVP, Business Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,933 Read SEC document |
| May 27, 2019 Filed May 28, 2019 22:23 UTC |
Kocher RollinSVP, Sales and Marketing
|
Tax withholdingCommon Stock | 1,496 | $29.38 | $43,952.48 |
DisclosureSEC source: 0001209191-19-033088 · doc4.xml · nonDerivative · entry 1 Kocher Rollin · CIK 0001684779 · SVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,638 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.